Navigation Links
Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
Date:4/15/2009

margins are negative. The reported clinical trial results demonstrated that when Medifocus's focused heat therapy alone was delivered prior to surgery, 0 of 34 (0%) of the tumors removed had positive margins whereas in the surgical arm without receiving the focused heat treatment, 4 of 41 or almost 10% had positive margins.

This study, along with the positive clinical efficacy results of another randomized study for the treatment of large breast cancer tumors that Medifocus reported last week, demonstrates that Medifocus's focused heat technology can potentially treat the majority of all localized and invasive breast cancer tumors detected. The study reported last week, demonstrated that when the Medifocus's focused heat was added to the standard of care (SOC) neo-adjuvant chemotherapy in the treatment of large breast cancer tumors, tumor shrinkage was increased by an additional 50% over that induced by (SOC) chemotherapy alone.

The treatment goal of the Medifocus study on early stage breast cancer, is to demonstrate that focused heat treatment delivered prior to surgery can improve surgical outcomes and decrease the need for re-excisions or a second incision which can improve cosmesis and may reduce recurrent rates of the breast cancer.

About Medifocus

Medifocus owns a patented microwave focusing technology (the Adaptive Phased Array ("APA") technology), which can precisely target and control microwave energy to cause heating in cancerous tumors anywhere in the body reliably and repeatedly. The ability to target tumors with a precision controlled dose of heat can be used to destroy tumors at higher temperatures, to treat tumors in combination with chemotherapy and/or radiation at moderate temperatures for increased effectiveness and reduced toxicity and to trigger the targeted release of therapeutic drugs and genes at tumor sites at lower temperatures. While the core technology has been licensed from the Massachusetts
'/>"/>

SOURCE Medifocus Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... The report “Atherosclerosis - ... Atherosclerosis is a slow, progressive disease that may start in childhood. The report ... best-in-class products. Complete report on Atherosclerosis Pipeline with 78 market data tables and ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... with its Topricin® Pain Relief and Healing Cream designated as the nonprofit’s natural ... that is actively addressing Line of Duty Deaths (LODD) and the high rate ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... shops are anticipating testing regulations imposed by the FDA for nicotine laced liquid ... use of electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction ...
(Date:7/29/2015)... San Fernando Valley, CA (PRWEB) , ... July 29, 2015 , ... ... offering a special promotional price on Ultherapy. For a limited time only, patients can ... Ultherapy is an option for patients who prefer a non-invasive treatment and have ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Wedding season is in full swing, which means ... extra pressure of looking good on the big day. Every bride wants to look and ... new level. , According to a recent study by the American ...
Breaking Medicine News(10 mins):Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3
... in the first phase of creating "designer lymph nodes." ... that are injected into patients and produce a pre-planned ... their bodies. The researchers are examining a cancer vaccine ... with advanced melanoma. "We used Moffitt,s Total Cancer ...
... Ph.D., R.D., F.A.D.A., a senior member and director of ... of a landmark book Nutritional Management of Cancer Treatment ... provides up-to-date information on novel nutritional approaches and strategies ... nutritional approaches may be used to alleviate them. ...
... of Medicine geriatricians are among only 83 advanced fellows ... $2.5 million in career development awards from The John ... one of the top-funded institutions. Award recipients from ... Iloabuchi, M.D., advanced geriatrics fellow joining IU faculty in ...
... Gordon HealthDay Reporter , FRIDAY, April 27 (HealthDay ... children with asthma to carry inhalers at school and 48 ... serious allergies, experts say that some kids are still ... day. "Every school district handles this a little bit ...
... 27 (HealthDay News) -- Two genetic variations are linked to ... according to new research. Glaucoma affects about 2.2 million ... said in a news release. "Loss of vision from ... irreversible damage to the optic nerve," noted one expert, Dr. ...
... HealthDay Reporter , THURSDAY, April 26 (HealthDay News) ... disabled Americans, may be hurtling toward the critical list, but ... their own wallets, a new Harris Interactive/HealthDay poll ... are needed to keep Medicare affordable and sustainable, and 51 ...
Cached Medicine News:Health News:Researchers creating designer lymph nodes based on Moffitt's Total Cancer Care initiative 2Health News:Moffitt researcher publishes book on nutritional management of cancer treatment effects 2Health News:Awards to 5 IU School of Medicine physicians address critical need for geriatricians 2Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 2Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 3Health News:Research Gets Closer to Genetic Roots of Glaucoma 2Health News:Americans Support Medicare Reform, But Not on Their Dime: Poll 2Health News:Americans Support Medicare Reform, But Not on Their Dime: Poll 3Health News:Americans Support Medicare Reform, But Not on Their Dime: Poll 4
(Date:7/29/2015)... , July 29, 2015 Breckenridge ... Azelastine HCl Nasal Solution, 0.1%. The U.S. Food and ... Drug Application (ANDA), which is AB rated to ... hydrochloride nasal solution (nasal spray) is a $69 ... IMS Health sales data.  Azelastine HCl Nasal Solution ...
(Date:7/29/2015)... 2015 P&S Market ... Industry Insight: Microfluidic Devices Market Development and ... DRO analysis, market segmentation, market size and ... and top competitor profiles.      ... Microfluidic devices  market is ...
(Date:7/29/2015)... Commenting on GSK,s Q2 performance, ... Simon Dingemans reveals sales rose during the period ... with expectations. Ahead of a November R&D update day ... The interview and transcript are available now on ... documentaries and webcasts with senior company executives. If you ...
Breaking Medicine Technology:Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Practice-oriented ophthalmic laser systems for photodisruption....
Medicine Products: